Lilly 3Q Revenues: $11.4 billion (+20%)  3Q Earnings: $970.3 million (loss of $57.4 million 3Q23)  YTD Revenues: $31.5 billion (+27%) YTD Earnings: $6.2 billion (+103%) Comments: Mounjaro sales were $3.1 billion in the quarter, up from $1.4 billion 3Q23. Verzenio sales were up 32% to $1.37 billion. Zepbound sales were $1.26 billion in the quarter. Trulicity sales were down 22% in the quarter to $1.3 billion.    Revenue in the U.S. increased 46% to $7.8 billion, driven by a 35% increase in...